BioDiem, Schering-Plough deal

BDM received an annual $1 million milestone payment from SGP's Nobilon International subsidiary under a 2004 licensing deal for BDM's intranasal influenza vaccine (see BioCentury, Dec. 6, 2004). BDM e...